[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"updates-archive-2026-09-23-28":3},{"date":4,"filings":5,"has_more":108,"limit":109,"page":110,"total_count":111},"2026-09-23",[6,14,18,26,30,37,41,46,50,55,59,64,68,75,82,86,93,97,104],{"company_name":7,"filing_date":8,"filing_source":9,"headline":10,"id":11,"stock_code":12,"summary_text":13},"Glenmark Pharmaceuticals Limited","2026-09-23T08:45:27.054000","NSE","Goa Facility Clears Key US FDA Inspection","6ab34478dc9a8790cc74772c","GLENMARK","*   The company received an Establishment Inspection Report (EIR) from the U.S. FDA for its Goa manufacturing facility.\n*   The facility was assigned a **Voluntary Action Indicated (VAI)** status, indicating the inspection is successfully closed.\n*   This is a positive regulatory outcome that mitigates the risk of supply disruptions to the U.S. market from this plant.\n*   The inspection was conducted from June 22, 2026, to June 30, 2026.",{"company_name":7,"filing_date":8,"filing_source":9,"headline":15,"id":16,"stock_code":12,"summary_text":17},"Goa Facility Receives Favorable US FDA Inspection Report","6ab3448a73074a3af61b17e1","*   **Event:** The company has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (U.S. FDA).\n*   **Facility:** The inspection was for the formulations manufacturing facility in Goa, India.\n*   **Outcome:** The facility received a **Voluntary Action Indicated (VAI)** classification.\n*   **Impact:** This is a positive outcome that closes the inspection and clears the facility to continue supplying the U.S. market, mitigating significant regulatory risk.",{"company_name":19,"filing_date":20,"filing_source":21,"headline":22,"id":23,"stock_code":24,"summary_text":25},"Lords Mark Industries Ltd","2026-09-23T08:35:27.621000","BSE","AI Breast Cancer Screening Tech Advances to Final Trials","6ab3421f58e45d3ba429b539","501261","*   The company's AI-powered, radiation-free breast cancer screening technology is advancing to the final clinical trial stage.\n*   Final trials are planned across the USA, Great Britain, and Europe, with Phase 2 trials commencing from January 2027.\n*   The company is targeting completion of trials by March 2027 and a commercial launch of the product by April 2027.\n*   Developed with C-MET, the portable device uses thermal sensors and AI for non-invasive screening, designed for remote and underserved areas.\n*   Regulatory approvals are in process in India (CDSCO) and being pursued for international markets (USA, Europe, UK).",{"company_name":19,"filing_date":20,"filing_source":21,"headline":27,"id":28,"stock_code":24,"summary_text":29},"AI Breast Cancer Screening Tech Enters Final Trial Stage","6ab3423ac8f6cdbfdae05074","*   The company has received approval for the final clinical trial stage of its AI-powered, radiation-free breast cancer screening technology.\n*   Final trials are scheduled to begin in January 2027 across India, the USA, Europe, and Great Britain, targeting 98% accuracy.\n*   A commercial launch of the product is targeted for April 2027, subject to successful trials and regulatory approvals.\n*   The technology is a wearable, portable, and painless device developed in collaboration with C-MET, designed for accessible screening in remote areas.",{"company_name":31,"filing_date":32,"filing_source":9,"headline":33,"id":34,"stock_code":35,"summary_text":36},"Prime Focus Limited","2026-09-23T08:30:26.882000","Prime Focus-linked AI venture, Brahma AI, raises $150M","6ab340f873074a3af61b17e0","PFOCUS","• Brahma AI, an entity built on technology from the Prime Focus group, has raised \u003Cb>$150 million\u003C\u002Fb> in a funding round.\n• The round was led by \u003Cb>Multiples Alternate Asset Management\u003C\u002Fb>, which contributed $100 million.\n• The investment validates the AI technology developed within the Prime Focus ecosystem (DNEG, Prime Focus Technologies) and could be value-accretive for shareholders.\n• Funds will be used to accelerate R&D, expand globally, and establish a significant Silicon Valley presence for Brahma AI.",{"company_name":31,"filing_date":32,"filing_source":9,"headline":38,"id":39,"stock_code":35,"summary_text":40},"New AI Venture Brahma AI Raises $150 Million","6ab34113853f8aacfe1b176e","*   A new, independent AI company, **Brahma AI**, has been formed by combining technology from Prime Focus group companies (DNEG, Prime Focus Technologies) and Metaphysic.\n*   Brahma AI has successfully raised **$150 million** in a funding round led by **Multiples Alternate Asset Management**.\n*   The new company will build an \"AI-native operating system for enterprise audiovisual content\" targeting verticals like Media & Entertainment, Sports, Healthcare, and Advertising.\n*   This formation and funding represent a significant value-unlocking event for Prime Focus Limited shareholders, monetizing the group's technology assets into a high-growth venture.",{"company_name":31,"filing_date":42,"filing_source":9,"headline":43,"id":44,"stock_code":35,"summary_text":45},"2026-09-23T08:20:26.945000","PFL-Backed Brahma AI Raises $150M at $2B Valuation","6ab33e9ddc9a8790cc74772b","*   Brahma AI, a Prime Focus-backed entity, has raised \u003Cb>$150 million\u003C\u002Fb> in a funding round led by \u003Cb>Multiples\u003C\u002Fb>.\n*   The transaction values Brahma AI at a \u003Cb>$2 billion\u003C\u002Fb> post-money valuation.\n*   Prime Focus Limited will remain the largest shareholder, holding a \u003Cb>c.66%\u003C\u002Fb> economic stake in Brahma AI.\n*   This is a significant value-unlocking event for PFL shareholders, establishing a high-growth enterprise AI platform alongside its DNEG creative business.\n*   Brahma AI has received an additional \u003Cb>$100 million\u003C\u002Fb> of investor demand and may upsize the round.",{"company_name":31,"filing_date":42,"filing_source":9,"headline":47,"id":48,"stock_code":35,"summary_text":49},"Backed AI Venture Brahma AI Raises $150M at $2B Valuation","6ab33eb658e45d3ba429b538","*   Prime Focus-backed AI venture, \u003Cb>Brahma AI\u003C\u002Fb>, has raised \u003Cb>$150 million\u003C\u002Fb> in an equity round led by Multiples.\n*   The fundraising values Brahma AI at a \u003Cb>$2 billion\u003C\u002Fb> post-money valuation.\n*   Prime Focus, through its subsidiary DNEG, will remain the largest economic shareholder with approximately \u003Cb>66% ownership\u003C\u002Fb>.\n*   The capital will be used to accelerate the development and global commercialization of Brahma AI's platform for audiovisual content.\n*   Brahma AI has received an additional \u003Cb>$100 million\u003C\u002Fb> of investor demand and is evaluating an upsize of the funding round.",{"company_name":31,"filing_date":51,"filing_source":9,"headline":52,"id":53,"stock_code":35,"summary_text":54},"2026-09-23T08:10:27.177000","Board Approves Major Restructuring & $100M Investment in Subsidiaries","6ab33c64c8f6cdbfdae05073","*   **Investment:** The Board has approved a USD 100 million investment from private equity firm \"Multiples\" into its material subsidiaries, Brahma AI Holdings Limited (BHL) and Brahma AI Services India Limited.\n*   **Corporate Restructuring:** Following the transaction, PFL will cease to have control over these subsidiaries, which will be reclassified as \"associate companies.\"\n*   **Shareholding Impact:** PFL will retain a majority economic interest of 65.67% in the entities, but its indirect voting rights in BHL will be reduced to 24.99%.\n*   **Shareholder Approval:** The entire transaction is subject to the prior approval of PFL's shareholders by way of a special resolution.",{"company_name":31,"filing_date":51,"filing_source":9,"headline":56,"id":57,"stock_code":35,"summary_text":58},"Board Approves $100M Investment & Restructuring of Brahma AI Subsidiaries","6ab33c7ebc0109c085e04f65","*   The Board has approved a proposed investment of **USD 100 million** from Multiples Private Equity into its material subsidiaries, Brahma AI Holdings Limited (BHL) and Brahma AI Services India Limited.\n*   Upon completion, PFL will cease to control these entities, and they will be reclassified from subsidiaries to **associate companies**.\n*   Despite the loss of control, PFL will retain a significant **65.67% economic interest** (shareholding) in both entities.\n*   The transaction is a primary fundraise to provide growth capital directly to the subsidiaries; PFL will not receive any consideration.\n*   The proposed cessation of control is subject to the approval of PFL's shareholders by way of a **special resolution**.",{"company_name":31,"filing_date":60,"filing_source":9,"headline":61,"id":62,"stock_code":35,"summary_text":63},"2026-09-23T08:10:27.117000","Multiples PE to Invest $100M in PFL's AI Subsidiaries, Triggering Restructuring","6ab33c6658e45d3ba429b537","*   Multiples Private Equity will invest USD 100 million into PFL's material subsidiaries, Brahma AI Holdings (BHL) and Brahma AI Services India.\n*   Following the transaction, PFL will cease to control these subsidiaries, and they will be reclassified as \"associate companies\".\n*   PFL's voting rights in BHL will be reduced to 24.99%, but it will retain a significant 65.67% economic interest.\n*   The deal is a primary fundraise for the subsidiaries; PFL will not receive any consideration.\n*   The transaction is subject to shareholder approval via a special resolution.",{"company_name":31,"filing_date":60,"filing_source":9,"headline":65,"id":66,"stock_code":35,"summary_text":67},"PFL Announces $100M Investment & Restructuring of AI Subsidiaries","6ab33c74dc9a8790cc74772a","*   **$100M Investment:** Multiples Private Equity to invest an aggregate of $100 million into subsidiaries Brahma AI Holdings (BHL) and Brahma AI Services India.\n*   **Major Restructuring:** BHL and Brahma India will cease to be subsidiaries of PFL and will be reclassified as \"associate companies.\" Their financials will no longer be consolidated.\n*   **Shift in Control:** PFL will cede control of the \"Brahma Group,\" with its indirect voting rights in BHL reducing from 89.27% to 24.99%.\n*   **Retained Economic Interest:** Despite losing control, PFL will retain a significant 65.67% economic interest in the Brahma Group, allowing it to benefit from future growth.\n*   **Shareholder Approval Required:** The transaction is subject to the prior approval of PFL's shareholders by way of a special resolution.",{"company_name":69,"filing_date":70,"filing_source":9,"headline":71,"id":72,"stock_code":73,"summary_text":74},"Orient Green Power Company Limited","2026-09-23T06:25:28.109000","Successfully Commissions 17.6 MW Solar Power Plant","6ab323be58e45d3ba429b536","GREENPOWER","*   A new 17.6 MW solar power plant has been commissioned in Tamil Nadu as of September 22, 2026.\n*   This completes the solar expansion objective that was committed by the company under its 2024 Rights Issue.\n*   The company's total aggregate installed solar capacity now stands at 24.6 MW.\n*   This capacity addition is expected to contribute to the company's future revenue and operational base.",{"company_name":76,"filing_date":77,"filing_source":9,"headline":78,"id":79,"stock_code":80,"summary_text":81},"Cholamandalam Investment and Finance Company Limited","2026-09-23T03:15:26.741000","Confirms Timely Payment of ₹ 600 Crore Commercial Paper","6ab2f746c8f6cdbfdae05072","CHOLAFIN","• The company has confirmed the timely payment of its Commercial Paper (ISIN: INE121A14YV5) on the due date, 22-Sep-2026.\n• A total maturity amount of ₹ 600 Crores (Rupees Six Hundred Crores) was paid in full.\n• This action demonstrates strong financial discipline and liquidity, reinforcing confidence in the company's ability to meet its financial commitments.\n• The update is a routine compliance certificate filed with the National Stock Exchange (NSE) as per SEBI regulations for listed Commercial Papers.",{"company_name":76,"filing_date":77,"filing_source":9,"headline":83,"id":84,"stock_code":80,"summary_text":85},"Confirms Timely Payment of ₹600 Crore Commercial Paper","6ab2f75973074a3af61b17df","*   The company has confirmed the timely payment of its Commercial Paper (ISIN: INE121A14YV5) obligation.\n*   A total of ₹600 Crore was paid on the due date, September 22, 2026.\n*   This repayment signals strong financial discipline and liquidity, a positive indicator for investors and creditors.",{"company_name":87,"filing_date":88,"filing_source":9,"headline":89,"id":90,"stock_code":91,"summary_text":92},"Bharat Forge Limited","2026-09-23T00:05:26.869000","Successfully Raises ₹ 2,000 Crores via QIP","6ab2caba58e45d3ba429b535","BHARATFORG","*   Successfully raised **₹ 2,000 Crores** through a Qualified Institutions Placement (QIP).\n*   Allotted **1,05,82,010 new equity shares** at an issue price of **₹ 1,890.00 per share**, a 2.96% discount to the floor price.\n*   The company's paid-up equity share capital has increased to ₹ 977.34 million, resulting in an equity dilution of approximately 2.21%.\n*   Major institutional investors like the **Government of Singapore, ICICI Prudential MF, and Invesco India MF** were among the key allottees, indicating strong market confidence.",{"company_name":87,"filing_date":88,"filing_source":9,"headline":94,"id":95,"stock_code":91,"summary_text":96},"Successfully Raises ₹20,000 Million via QIP","6ab2cac2853f8aacfe1b176d","*   Successfully completed a Qualified Institutions Placement (QIP), raising \u003Cb>₹ 20,000 million\u003C\u002Fb>.\n*   Allotted \u003Cb>1,05,82,010 new equity shares\u003C\u002Fb> at an issue price of \u003Cb>₹ 1,890.00 per share\u003C\u002Fb>.\n*   This results in an equity dilution of approximately \u003Cb>2.21%\u003C\u002Fb> for existing shareholders.\n*   Major allottees include the \u003Cb>Government of Singapore\u003C\u002Fb> (16.81% of the issue) and \u003Cb>ICICI Prudential Mutual Fund\u003C\u002Fb> (10.00% of the issue).\n*   The company's paid-up equity share capital has increased to \u003Cb>₹ 977.34 million\u003C\u002Fb>.",{"company_name":98,"filing_date":99,"filing_source":9,"headline":100,"id":101,"stock_code":102,"summary_text":103},"3i Infotech Limited","2026-09-23T00:05:26.451000","Allots Equity Shares Under Employee Stock Option Schemes","6ab2cab573074a3af61b17db","3IINFOLTD","*   Allotted 98,237 new equity shares to employees on September 22, 2026, upon the exercise of vested stock options.\n*   The allotment was made under the company's Employee Stock Option Scheme 2018 (ESOS 2018) and Employee Stock Option Plan 2023 (ESOP 2023).\n*   Following the allotment, the company's issued and paid-up equity share capital has increased to 2,075,020,040 shares.\n*   **Note:** The filing contains a discrepancy. While 98,237 shares were reportedly allotted, the change in share capital figures suggests an increase of 982,370 shares.",{"company_name":98,"filing_date":99,"filing_source":9,"headline":105,"id":106,"stock_code":102,"summary_text":107},"Allots Equity Shares to Employees Under ESOP","6ab2cabadc9a8790cc747729","*   The company allotted 98,237 new equity shares of ₹10 each to employees upon the exercise of stock options.\n*   The allotment was made under the Employee Stock Option Scheme 2018 (ESOS 2018) and Employee Stock Option Plan 2023 (ESOP 2023).\n*   Following the allotment, the total number of issued and paid-up equity shares stands at 2,075,020,040.\n*   **Note:** A discrepancy was noted in the filing. While the descriptive text states 98,237 shares were allotted, the structured data (XBRL) indicates an allotment of 982,370 shares.",false,100,28,2719]